"There is a common expectation that coffee increases alertness and...
Category:
Health
Latest
Delhi has become India’s electric vehicle capital: CM Arvind Kejriwal
We introduced the Electric Vehicle Policy in August 2020. Our...
Transgender people at higher risk of suicide: Study
“The observed excess of suicidal behaviour and mortality might, at...
No ‘serious or severe’ adverse effect post COVID-19 immunisation report so far: Govt
A total of 3,81,305 beneficiaries have so far been vaccinated for COVID-19 and 580 adverse events following immunisation were reported in the country till now, the Union health ministry said on Monday.
He said a cumulative 580 adverse events following immunisation (AEFI) and seven cases of hospitalisation have so far been reported in the country since the nationwide COVID-19 inoculation drive began on January 16.
Indian companies consider buying vaccines for employees
Steel producer Jindal Steel and Power Ltd, autos-to technology conglomerate Mahindra Group and consumer goods giant ITC Ltd have begun initial checks on vaccines being available to buy after the government covers priority segments.
World on brink of “Catastrophic Moral Failure” on vaccines: WHO Chief
The global scramble for shots has intensified as more infectious virus variants circulate.Tedros said more than 39 million vaccine doses had been administered in 49 higher-income countries whereas just 25 doses had been given in one poor country.
He said even as some countries pronounced reassuring words on equitable access, they were prioritising their own deals with manufacturers, driving up prices and trying to jump the queue.
Steel companies engage with vaccine makers for bulk supply of doses for employees
State-owned RINL and Steel Authority of India Limited (SAIL) have sent details of its employees to the administration and who will be vaccinated based on priority.
Both SAIL and RINL also run hospitals at their plant sites.
A Tata Steel spokesperson said the company has been working very closely with the government and respective state governments of Jharkhand and Odisha from the start of the pandemic and serving the community with medical facilities at various locations of its operations.
India reports 70 lakh burn injuries annually with 1.4 lakh mortality rate:Harsh Vardhan
“Burn injury is one of the biggest causes of workforce loss and this is an issue of concern for countries like India. The nation reports as many as 70 lakh burn injuries annually with a mortality rate as high as 1.4 lakh per year and an additional 2.4 lakh patients end up with severe deformities. Due to its large population, most of the burn care facilities are overburdened and the state-of-the-art burn care is negligible. There is a dire need for a healthcare facility that can provide high-quality care for a large fraction of the population. The new Burns and Plastic Surgery Block has been conceived with the vision of providing state-of-the-art care in the field of burns management and research at All India Institute of Medical Sciences, Delhi.,” Vardhan said at the inauguration ceremony.
Norway says no link between vaccine and post-jab deaths
The Norwegian Medicines Agency said last week that normal side effects from messenger RNA vaccines, such as fever and nausea, “may have contributed to a fatal outcome in some frail patients.”
A number of countries, including Norway’s neighbours Denmark, Finland, Iceland and Sweden, have reported post-vaccination deaths but no direct links to the vaccine have been established.
Allianz Risk Barometer 2021: Covid-19 trio tops global and Asia Pacific business risks
“The Allianz Risk Barometer 2021 is clearly dominated by the Covid-19 trio of risks. Business interruption, pandemic and cyber are strongly interlinked, demonstrating the growing vulnerabilities of our highly globalized and connected world,” says Joachim Müller, CEO of AGCS.
“The coronavirus pandemic is a reminder that risk management and business continuity management need to further evolve in order to help businesses prepare for, and survive, extreme events. While the pandemic continues to have a firm grip on countries around the world, we also have to ready ourselves for more frequent extreme scenarios, such as a global-scale cloud outage or cyber-attack, natural disasters driven by climate change or even another disease outbreak,” he said.
Pfizer vaccine worries Norway as 29 elderly people die after taking shot
Official reports of allergic reactions have been rare as governments rush to roll out vaccines to try to contain the global pandemic. U.S. authorities reported 21 cases of severe allergic reactions from Dec. 14-23 after administration of about 1.9 million initial doses of the Pfizer vaccine. The first Europe-wide safety report on the Pfizer-BioNTech vaccine is due to be published at the end of January.
2,24,301 beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt
Addressing a press briefing, the ministry”s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation
Metropolis Healthcare to acquire Hitech Diagnostic Centre in a cash, stock deal
By the acquisition, Metropolis will get an access to 31 laboratories, including three NABL- and ICMR-accredited laboratories and 68 collection centres of Hitech. The acquisition is expected to be completed within three months, it added.
Metropolis Healthcare Managing Director Ameera Shah said, “In line with the strategy to grow, gain market share and increase B2C (business-to-consumer) revenues in focus cities, we are acquiring Hitech Diagnostic Centre which will strengthen our leadership position in the South India market.”